Profile data is unavailable for this security.
About the company
SyntheticMR AB (publ) is a Sweden-based company that develops and markets software solutions for Magnetic Resonance Imaging (MRI). The Company provides SyMRI, which measures the absolute properties of the brain and delivers adjustable contrast images, automatic biomarker segmentation and quantitative data in a single MR scan. The SyMRI product is available in different packages. SyMRI IMAGE provides fast MRI workflows, allowing high patient throughput. SyMRI NEURO enables automatic segmentation of brain tissue, providing objective decision support. SyMRI Research Edition includes exportable SyMaps, parametric common contrast weighted images and maps of the brain, allowing the investigation to be taken even further. SyMRI is a registered trademark in Europe and in the USA.
- Revenue in SEK (TTM)90.86m
- Net income in SEK15.67m
- Incorporated2007
- Employees38.00
- LocationSyntheticMR AB (publ)Storgatan 11LINKOPING 582 23SwedenSWE
- Phone+46 13101650
- Websitehttps://www.syntheticmr.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gentian Diagnostics ASA | 140.09m | -5.75m | 635.00m | 58.00 | -- | 4.26 | 180.07 | 4.53 | -0.3783 | -0.3783 | 9.22 | 9.82 | 0.7646 | 1.85 | 6.35 | 2,452,035.00 | -3.14 | -10.76 | -3.58 | -11.86 | 50.84 | 41.46 | -4.10 | -26.99 | 4.14 | -- | 0.0555 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
Moberg Pharma AB (publ) | 820.00k | -22.56m | 656.21m | 9.00 | -- | 1.07 | -- | 800.26 | -1.09 | -1.09 | 0.0379 | 21.63 | 0.0014 | -- | 0.2841 | -- | -3.81 | -- | -3.96 | -- | 60.00 | -- | -2,751.22 | -- | 1.73 | -- | 0.0073 | -- | -100.00 | -- | -34.26 | -- | -- | -- |
Oncopeptides AB | 39.17m | -245.79m | 704.83m | 62.00 | -- | -- | -- | 17.99 | -1.93 | -1.93 | 0.3085 | -0.0664 | 0.1517 | -0.2669 | 0.8075 | 687,157.90 | -95.16 | -141.28 | -135.11 | -200.49 | 102.05 | -- | -627.53 | -2,689.06 | 2.33 | -- | 1.06 | -- | 321.54 | -- | 26.29 | -- | -- | -- |
Intellego Technologies AB | 186.49m | 59.60m | 719.43m | 62.00 | 11.71 | 4.76 | 11.40 | 3.86 | 2.33 | 2.33 | 7.35 | 5.74 | 0.8841 | 3.87 | 3.69 | 3,007,968.00 | 28.26 | -- | 44.00 | -- | 68.73 | -- | 31.96 | -- | 2.07 | 5.82 | 0.1684 | -- | 222.74 | -- | 493.56 | -- | -- | -- |
Orexo AB | 619.10m | -73.40m | 725.45m | 113.00 | -- | 11.73 | 125.08 | 1.17 | -2.13 | -2.13 | 17.98 | 1.78 | 0.6959 | 1.08 | 2.53 | 5,337,069.00 | -8.25 | -6.41 | -20.27 | -9.99 | 88.14 | 86.76 | -11.86 | -11.83 | 0.589 | 0.1386 | 0.8948 | -- | 2.32 | -3.99 | 27.76 | -- | 25.77 | -- |
Nightingale Health Oyj | 41.61m | -205.63m | 757.23m | 81.00 | -- | 1.13 | -- | 18.20 | -0.2979 | -0.2979 | 0.0603 | 1.50 | 0.0344 | 1.60 | 3.87 | 44,560.98 | -17.02 | -14.20 | -18.12 | -15.69 | 75.81 | 83.57 | -494.25 | -408.50 | 14.15 | -- | 0.0378 | -- | 80.80 | 19.05 | -12.38 | -- | -- | -- |
IRLAB Therapeutics AB | 5.68m | -157.30m | 787.19m | 28.00 | -- | 10.27 | -- | 138.64 | -3.03 | -3.03 | 0.1095 | 1.48 | 0.0274 | -- | 0.4652 | 218,384.60 | -75.97 | -27.12 | -94.23 | -30.42 | -1,952.47 | -72.18 | -2,770.38 | -155.57 | -- | -- | 0.2646 | -- | -90.71 | 216.07 | -56.82 | -- | -22.56 | -- |
Alligator Bioscience AB | 55.49m | -248.80m | 877.81m | 55.00 | -- | -- | -- | 15.82 | -0.4848 | -0.4848 | 0.0999 | -0.0772 | 0.5289 | -- | 8.07 | 956,741.40 | -237.13 | -73.26 | -- | -91.33 | -- | -- | -448.35 | -811.68 | -- | -104.20 | -- | -- | 62.78 | 16.60 | -28.53 | -- | -20.34 | -- |
Cantargia AB | 0.00 | -241.07m | 878.02m | 23.00 | -- | 6.60 | -- | -- | -1.40 | -1.40 | 0.00 | 0.7239 | 0.00 | -- | -- | 0.00 | -83.14 | -55.08 | -107.52 | -61.35 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.69 | -- | -- | -- |
BioPorto A/S | 49.42m | -82.15m | 967.75m | 27.00 | -- | 15.20 | -- | 19.58 | -0.1501 | -0.1501 | 0.0903 | 0.1099 | 0.4132 | 3.66 | 7.33 | 1,044,452.00 | -68.68 | -71.10 | -100.20 | -96.55 | 68.08 | 63.38 | -166.23 | -239.22 | 2.36 | -- | 0.1354 | -- | 6.87 | 3.54 | 25.81 | -- | -51.56 | -- |
Vistin Pharma ASA | 431.77m | 55.39m | 987.19m | 77.00 | 17.82 | 3.37 | 13.53 | 2.29 | 1.27 | 1.27 | 9.88 | 6.70 | 1.11 | 2.31 | 7.44 | 5,692,663.00 | 14.28 | 1.73 | 18.93 | 2.11 | 59.93 | 58.92 | 12.83 | 2.36 | 0.8536 | 32.96 | 0.0934 | -- | 51.35 | 16.95 | 1,066.84 | -- | -0.1922 | -- |
Diamyd Medical AB | 282.00k | -120.18m | 1.15bn | 26.00 | -- | 6.25 | -- | 4,092.84 | -1.41 | -1.41 | 0.0033 | 1.91 | 0.0014 | -- | 6.56 | 11,280.00 | -59.77 | -25.46 | -66.19 | -28.37 | -4,930.85 | -1,419.23 | -42,617.73 | -5,896.43 | -- | -130.78 | 0.1176 | -- | 20.26 | -5.54 | -12.13 | -- | -- | -- |
SyntheticMR AB (publ) | 90.86m | 15.67m | 1.16bn | 38.00 | 73.34 | 9.68 | 52.63 | 12.80 | 0.3804 | 0.3804 | 2.21 | 2.88 | 0.6719 | -- | 1.58 | 2,455,541.00 | 11.59 | 7.19 | 13.87 | 8.85 | 73.94 | 69.70 | 17.25 | 9.08 | -- | -- | 0.0083 | 21.50 | 30.67 | 13.05 | 70.34 | -7.33 | 27.30 | -- |
Cereno Scientific AB | 0.00 | -59.13m | 1.22bn | 5.00 | -- | 5.05 | -- | -- | -0.281 | -0.281 | 0.00 | 0.8598 | 0.00 | -- | -- | 0.00 | -24.71 | -16.81 | -26.65 | -18.26 | -- | -- | -- | -- | -- | -10.70 | 0.1843 | -- | -- | -- | -73.95 | -- | 44.79 | -- |
Arcticzymes Technologies ASA | 115.98m | 17.29m | 1.30bn | 68.00 | 75.22 | 4.20 | 55.26 | 11.19 | 0.3443 | 0.3443 | 2.30 | 6.17 | 0.3562 | 0.4228 | 6.29 | 1,731,471.00 | 5.31 | 15.58 | 5.66 | 17.22 | 95.50 | 96.69 | 14.91 | 33.23 | 12.14 | -- | 0.0327 | 0.00 | -13.16 | 12.24 | -40.89 | -- | 47.93 | -- |
Infant Bacterial Therapeutics AB | 0.00 | -128.42m | 1.31bn | 9.00 | -- | 4.88 | -- | -- | -9.96 | -9.96 | 0.00 | 20.59 | 0.00 | -- | -- | 0.00 | -37.63 | -16.11 | -43.78 | -16.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -88.03 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Handelsbanken Fonder ABas of 30 Apr 2024 | 2.07m | 0.00% |
Swedbank Robur Fonder ABas of 29 Feb 2024 | 2.03m | 0.00% |
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Dec 2022 | 1.87m | 0.00% |
Aktia Fondbolag Abas of 30 Apr 2024 | 915.34k | 0.00% |
Aktia Bank Plc (Investment Management)as of 31 Dec 2022 | 915.34k | 0.00% |
Fondita Fund Management Co. Ltd.as of 31 Mar 2024 | 500.00k | 0.00% |
Axxion SA (Luxembourg)as of 28 Mar 2024 | 53.34k | 0.00% |
AIFM Capital ABas of 31 Dec 2021 | 1.07k | 0.00% |